Search: onr:"swepub:oai:lup.lub.lu.se:ac8763d8-144e-4559-8172-5b8647ee87b5" >
Interleukin-4 reduc...
Interleukin-4 reduces insulin secretion in human islets from healthy but not type-2 diabetic donors
-
- Westholm, Efraim (author)
- Lund University,Lunds universitet,Diabetes - öcellsexocytos,Forskargrupper vid Lunds universitet,Diabetes - Islet Cell Exocytosis,Lund University Research Groups,Skåne University Hospital
-
- Edlund, Anna (author)
- Lund University,Lunds universitet,Diabetes - öcellsexocytos,Forskargrupper vid Lunds universitet,Luftvägar, patogener, immunförsvar,Diabetes - Islet Cell Exocytosis,Lund University Research Groups,Airways, pathogens, innate immunity,Skåne University Hospital
-
- Karagiannopoulos, Alexandros (author)
- Lund University,Lunds universitet,Diabetes - öcellsexocytos,Forskargrupper vid Lunds universitet,Diabetes - Islet Cell Exocytosis,Lund University Research Groups,Skåne University Hospital
-
show more...
-
- Wendt, Anna (author)
- Lund University,Lunds universitet,Diabetes - öcellsexocytos,Forskargrupper vid Lunds universitet,Diabetes - Islet Cell Exocytosis,Lund University Research Groups,Skåne University Hospital
-
- Eliasson, Lena (author)
- Lund University,Lunds universitet,Diabetes - öcellsexocytos,Forskargrupper vid Lunds universitet,Diabetes - Islet Cell Exocytosis,Lund University Research Groups,Skåne University Hospital
-
show less...
-
(creator_code:org_t)
- Elsevier BV, 2023
- 2023
- English 6 s.
-
In: Biochemical and Biophysical Research Communications. - : Elsevier BV. - 1090-2104 .- 0006-291X. ; 649, s. 87-92
- Related links:
-
http://dx.doi.org/10... (free)
-
show more...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Type 2 diabetes (T2D) is associated with low-grade inflammation. Here we investigate if the anti-inflammatorycytokine interleukin-4 (IL-4) affects glucose-stimulated insulin secretion (GSIS) in human islets from nondiabetic(ND) and type-2 diabetic (T2D) donors. We first confirmed that GSIS is reduced in islets from T2Ddonors. Treatment with IL-4 for 48 h had no further effect on GSIS in these islets but significantly reduced secretionin ND islets. Acute treatment with IL-4 for 1 h had no effect on GSIS in ND islets which led us to suspect thatIL-4 affects a slow cellular mechanism such as gene transcription. IL-4 has been reported to regulate miR-378a-3pand, indeed, we found that this microRNA was increased with IL-4 treatment. However, overexpression of miR-378a-3p in the human beta cell line EndoC-βH1 did not affect GSIS. MiR-378a-3p is transcribed from the samegene as peroxisome proliferator-activated receptor gamma co-activator 1 beta (PCG-1β) and we found that IL-4treatment showed a clear tendency to increased gene expression of PCG-1β. PCG-1β is a co-activator of peroxisomeproliferator-activated receptor gamma (PPARγ) and, the gene expression of PPARγ was also increased withIL-4 treatment. Our data suggests that the protective role of IL-4 on beta cell survival comes at the cost of loweredinsulin secretion, presumably involving the PPARγ-pathway.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Keyword
- IL-4
- Beta cell
- Diabetes
- Insulin secretion
- microRNA
- PPARγ
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database